ArticleNature biotechnology2026
An AI-enabled structural atlas decodes kinase specificity across the human proteome.
Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Of the 1.8 million serine/threonine/tyrosine residues in the human proteome, only 6% bear experimental validation of phosphorylation, and only 5% of these have been mapped to a kinase. Here we present KinoPlex, a computational framework that integrates predicted protein structures and kinase recognition motifs to assign phosphorylation potential and kinase specificity to all serine/threonine/tyrosine residues. Using ~20,000 AlphaFold models and positive-unlabeled transfer learning, we identified ~567,000 residues as structurally phospho-competent. We intersected these with kinase position-specific scoring matrices to quantify motif specificity, yielding ~250,000 high-confidence candidates with sequence recognition potential and optimal structural presentation. The structural atlas uncovered fundamental organizing principles guiding kinase substrate recognition and dynamics of phosphorylation, including a phenomenon we call sequence-structure selective coupling, whereby kinases achieve specificity through structural scarcity of their preferred motif (negative-selecting kinases) or promiscuity through its structural accessibility (positive-selecting kinases), rather than by motif discrimination alone. Deep phosphoproteomics in K562 cells validates KinoPlex predictions and kinase enrichment capacities.
Identifiers
42527527What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.